Everest Organics board approves unaudited financial results

08 Feb 2021 Evaluate

Everest Organics has informed that the Board of Directors of the Company at its meeting held on February 08, 2021, considered and approved the Unaudited Financial Results for the third quarter ended December 31, 2020 and declaration of payment of Interim Dividend for the financial year 2020-21.

The above information is a part of company’s filings submitted to BSE.

Everest Organics Share Price

437.15 25.45 (6.18%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×